Stockreport

How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91% [Yahoo! Finance]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $49.33 indicates a 37.9% upside potential. The [Read more]